Front-Line Transplantation Program with Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients with Multiple Myeloma: A Phase II Study by the Intergroupe Francophone Du Myélome